Quinolinic acid is an endogenous excitotoxin produced through the kynurenine pathway of tryptophan metabolism. It acts as a selective NMDA receptor agonist, making it a valuable research tool for studying excitotoxicity, neurodegenerative diseases, and neuroinflammation in both in vitro and in vivo models.
